This role reports to the Head of Market Access Legal and will partner closely with the business, the North America General Counsel, the Head of Litigation, the Head of Public Policy & Corporate Affairs, and Communications among others to define Sanofi's internal positions, shape affirmative litigation and advocacy strategy, and help design and defend internal programs that advance Sanofi's interests and the interests of patients. This is not a role that owns a single program it is a role that helps the Law Division think and act strategically across the full landscape of U.S. government pricing and drug pricing reform, including the 340B Drug Pricing Program, PBM reform, Most Favored Nation (MFN) implementation, IRA drug price negotiation, and related federal and state policy developments.